Hair Loss (Alopecia): Causes, Pathophysiology, and Long-Term Effects

By Guillermo Salinas Araya · June 1, 2026 · Educational Material

The skin is an active endocrine organ that produces, metabolizes, and responds to more than 30 different hormones. That's why seemingly cosmetic conditions — alopecia, acanthosis nigricans, adult acne — are often signs of something much deeper.

Medical Definition of Alopecia

The term alopecia refers to a clinical condition with diagnostic criteria established in recent medical literature. Understanding it requires distinguishing between the entity itself, its presentation forms, and its underlying mechanisms. Updated international guidelines have reformulated several of these criteria in the last decade, expanding what conventional clinical practice has not yet incorporated.¹

Pathophysiology: How It Develops

The pathophysiological cascade of alopecia involves multiple parallel mechanisms that feed back on each other. The monocausal hypothesis has been replaced by integrative models that recognize the interaction of several axes:²

• Endocrine-metabolic axis: altered insulin sensitivity and hepatic lipogenesis.
• Inflammatory axis: low-grade pro-inflammatory cytokines (TNF-α, IL-6, elevated high-sensitivity CRP).
• Mitochondrial axis: respiratory chain dysfunction and increased reactive oxygen species.
• Intestinal axis: microbiome alteration, increased intestinal permeability, endotoxin translocation.
• Neuroendocrine axis: dysregulation of the hypothalamic-pituitary-adrenal axis with chronically elevated cortisol.

The simultaneous accumulation of these five impacts is what distinguishes the pathological state from the physiological state of compensatory tolerance. Patients can spend years with one or two active axes without clinical manifestation — until convergence overwhelms adaptation mechanisms.

Clinical Signs and Symptoms

Clinical presentation is heterogeneous. In early stages, most patients are oligosymptomatic or asymptomatic.³ Signs and symptoms that guide diagnosis include:

• Unexplained fatigue, especially postprandial
• Progressive increase in abdominal circumference
• Skin changes (spots, papules, hair alterations)
• Sleep-wake cycle disturbances
• Neurocognitive symptoms: brain fog, difficulty concentrating, irritability
• Nonspecific laboratory findings: mildly elevated CRP, mild hepatic or lipid alterations frequently categorized as "high normal"
• Subtle ultrasound findings requiring directed examination

Long-Term Consequences if Left Unaddressed

The natural history of alopecia without adequate intervention involves silent but predictable progression:⁴

• Increased cardiovascular risk independent of cholesterol
• Accelerated development of type 2 diabetes in patients with prediabetes
• Progression toward structural organ damage within 5 to 15 years
• Increased oncological risk documented in longitudinal cohorts
• Progressive functional deterioration that reduces quality of life and healthy life expectancy

The therapeutic opportunity window — the period during which the condition is completely reversible — is proportional to exposure time and the number of compromised pathophysiological axes. Each year lost without comprehensive intervention reduces that window.

Can It Be Reversed?

Contemporary clinical evidence is conclusive: in pre-irreversible stages, reversal is possible. But it requires addressing all five pathophysiological axes simultaneously, not sequentially or in isolation. This is where conventional approaches fail: they intervene on a single axis and leave the other four active.

The educational protocol we designed — The Salinas Method — includes 8 sequential phases. Each phase addresses a different mechanism in the cascade. Phases 1 and 2 prepare the cellular terrain and correct the microbiome. Phases 3 through 6 dismantle low-grade inflammation, mitochondrial dysfunction, insulin resistance, and cortisol axis disruption. Phases 7 and 8 consolidate the change and prevent recurrence.

It's not a diet. It's not isolated fasting. It's not a supplement. It's a guided educational protocol, step by step, based on the most recent clinical evidence and designed so patients understand the rationale behind each action.

References

1. Olsen EA, et al. Hair and Scalp Disorders. J Am Acad Dermatol. 2003. PubMed
2. Strazzulla LC, et al. Alopecia areata: Disease characteristics. J Am Acad Dermatol. 2018. PubMed
3. Higgins CA, et al. The genetics, molecular biology, and inheritance of androgenetic alopecia. Br J Dermatol. 2014. PubMed
4. Sinha A, et al. Acanthosis Nigricans. J Dermatol. 2007. PubMed

100% educational material. Does not replace personal medical consultation. References verifiable on PubMed.